Phase 4Not yet recruiting
Combating Related Epidemics in HCV (CREST)
Combating Related Epidemics in HCV Through Simplified Testing and Treatment. A Cluster Randomized Trial of Point-of-care Hepatitis C Testing and Treatment Among Key Populations
- Sponsor
- Duke University (Academic or other)
- Enrollment
- 1,280 planned
- Conditions
- HIV - Human Immunodeficiency Virus; Hepatitis B Virus (HBV); HEPATITIS C (HCV)
- Interventions
- Cepheid GeneXpert HCV Test; INSTI HIV - 1/2 Antibody; bioLytical Laboratories iStatis Hepatitis B Surface Antigen Test; Sofosbuvir / Velpatasvir Oral Tablet [Epclusa]; Sofosbuvir/Velpatasvir/Voxilaprevir
- Ages
- children, adults, older adults
- Registry
- NCT07560046
Full record on ClinicalTrials.gov
From the registry
This is a two-arm cluster randomized control trial to evaluate the effectiveness of a single-visit point-of-care (POC) test and treat bundle (intervention arm) compared to the current standard-of-care (SOC, control arm). 1:1 randomization occurs at the site level.
Primary outcomes
- Proportion of participants who complete the Hepatitis C Virus (HCV) care cascade within 24 weeks of study entry in intervention versus Standard of Care (SOC) arm.
History
Study completion expected
Primary completion expected
Expected to start
Last registry update
Registered